Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1CNS 1

Conditions

Ovarian High Grade Serous Adenocarcinoma 1Medulloblastoma 1Locally Advanced Non-Small Cell Lung Cancer 1Leukemia, Myeloid, Acute 1Glioma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Atovaquone × 1 year × Clear all
NCT04648033 2026-01-29

ARCADIAN

University of Oxford

Phase 1 Completed
21 enrolled 21 charts
Thoracic

Locally Advanced Non-Small Cell Lung Cancer

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed
26 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting
28 enrolled
Gynecologic

Ovarian High Grade Serous Adenocarcinoma

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting
18 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡